Press release
2025-2034 Radiopharmaceutical Theranostics Market Roadmap: Insights for Competitive Advantage
Radiopharmaceutical Theranostics
How Large Will the Radiopharmaceutical Theranostics Market Size By 2025?
The market size of radiopharmaceutical theranostics has experienced rapid growth in the past few years. It is projected to increase from $2.88 billion in 2024 to $3.27 billion in 2025, with a compound annual growth rate (CAGR) of 13.7%. This growth during the historical period is due to factors such as development in radiopharmaceuticals, advancements in clinical research, investment in research, regulatory approvals, and the progression of nuclear medicine.
How Big Is the Radiopharmaceutical Theranostics Market Size Expected to Grow by 2029?
Anticipated to witness a swift expansion in the upcoming years, the radiopharmaceutical theranostics market size is projected to reach $5.76 billion by 2029, growing at a compound annual growth rate (CAGR) of 15.2%. The projected growth during this period can be linked to developments in biomarker discovery and validation, advancements in genomic and proteomic methods, the evolution of precision radiotherapy, interdisciplinary collaborations, and amplified patient advocacy and support. The pivotal trends envisioned for the forecast period encompass ethical and legal aspects, the integration of telemedicine in theranostics, patient-centered care approaches, personalized radiopharmaceutical solutions, and the progression of nano-theranostics.
View the full report here:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-theranostics-global-market-report
Which Key Market Drivers Powering Radiopharmaceutical Theranostics Market Expansion and Growth?
The predicted increase in cancer rates is anticipated to boost the development of the radiopharmaceutical theranostics market. Cancer is characterized as a disease or condition that involves an irregular and complicated cell growth that can metastasize to other areas of the body. Radiopharmaceutical theranostics contribute to cancer therapy through personalized and targeted strategies. For example, in 2023, as per the American Cancer Society, a voluntary cancer health entity based in the US, there are estimated to be 1.9 million new cancer diagnoses and roughly 609,820 cancer-related deaths in the US. Moreover, it is expected that 88% of the diagnosed individuals will be from the age group of 50 years and older. Consequently, the escalating occurrence of cancer is spurring the growth of the radiopharmaceutical theranostics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11951&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Radiopharmaceutical Theranostics Market?
Key firms in the radiopharmaceutical theranostics market are utilizing strategic collaborations to create innovative treatments. Such partnerships offer advantages to radiopharmaceutical theranostics firms like pooling resources and expertise, boosting R&D abilities, widening market penetration, and hastening the commercialization process, ultimately propelling innovation and expansion in the radiopharmaceutical theranostics sector. For instance, Radiopharm Theranostics, a biotech company from Australia, forged a partnership in March 2023 with Pharma15 Corporation, an American enterprise, to work on developing advanced therapeutic radiopharmaceuticals focused on treating prostate cancer. This collaboration specifically aims to resolve resistance to existing PSMA-targeted treatments while improving selectivity to reduce toxicity in non-cancerous tissues.
What Are the Emerging Segments in the Radiopharmaceutical Theranostics Market?
The radiopharmaceutical theranostics market covered in this report is segmented -
1) By Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers
2) By Source: Nuclear Reactors, Cyclotrons
3) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes
4) By Indication: Oncology, Cardiology, Neurology, Other Indications
5) By End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users
Subsegments:
1) By Alpha Emitters: Actinium-225, Radium-223, Bismuth-213, Other Alpha-Emitting Radiopharmaceuticals
2) By Beta Emitters: Iodine-131, Lutetium-177, Yttrium-90, Other Beta-Emitting Radiopharmaceuticals
3) By Positron Emission Tomography (PET) Tracers: Fluorodeoxyglucose (FDG), Gallium-68, Carbon-11, Other PET Tracers
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11951&type=smp
Who Are the Global Leaders in the Radiopharmaceutical Theranostics Market?
Major companies operating in the radiopharmaceutical theranostics market include Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd.
Which are the Top Profitable Regional Markets for the Radiopharmaceutical Theranostics Industry?
North America was the largest region in the radiopharmaceutical theranostics market in 2024. The regions covered in the radiopharmaceutical theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11951
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Radiopharmaceutical Theranostics Market Roadmap: Insights for Competitive Advantage here
News-ID: 4100403 • Views: …
More Releases from The Business Research Company
Future Perspective: Key Trends Shaping the Signal Conditioning Modules Market Up …
The signal conditioning modules market is on track for significant expansion over the coming years, driven by advancements in various industrial and technological sectors. This growth reflects the increasing need for precise signal management and integration with emerging smart technologies that are shaping modern automation and data acquisition systems.
Projected Growth Trajectory of the Signal Conditioning Modules Market
The signal conditioning modules market is anticipated to reach a valuation of $1.77…
Emerging Sub-Segments Transforming the Set-Top Box Market Dynamics
The set-top box market is on the cusp of significant expansion as technology and consumer preferences continue to evolve rapidly. With the increasing demand for advanced streaming and broadcasting solutions, this sector is poised for substantial growth over the coming years. Let's explore the market's projected size, leading companies, key trends, and the segments driving this development.
Projected Market Growth of the Set-Top Box Industry by 2030
The set-top box market…
Market Trend Analysis: The Impact of Recent Innovations on the Semiconductor Waf …
The semiconductor wafer sector is gearing up for significant expansion as technological advancements and diverse industry demands drive its growth. With applications spanning from electric vehicles to telecommunications, this market is positioned for steady development in the years ahead. Let's explore the anticipated market size, key players, emerging trends, and segmentation details shaping the future of this vital industry.
Projected Market Size and Growth Trajectory of the Semiconductor Wafer Market
Forecasts…
Leading Companies Reinforce Their Presence in the Semiconductor Manufacturing Eq …
The semiconductor manufacturing equipment market is poised for significant expansion as the demand for high-performance chips and advanced packaging technologies continues to grow. This evolving sector is driven by technological progress and increased investments, setting the stage for substantial developments through 2030.
Projected Semiconductor Manufacturing Equipment Market Size and Growth
The semiconductor manufacturing equipment market is forecasted to reach a value of $196.07 billion by 2030, growing at a compound annual…
More Releases for Radiopharm
Steady Expansion Forecast for Radiopharmaceutical Theranostics Market, Projected …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Radiopharmaceutical Theranostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The global market for radiopharmaceutical theranostics has experienced substantial expansion lately, projected to increase from its 2024 valuation of $2.88 billion to reach $3.27 billion by 2025, demonstrating a robust compound annual growth rate of…
Strong Growth Ahead: Radiopharmaceutical Theranostics Market Size To Grow At Are …
The Radiopharmaceutical Theranostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Radiopharmaceutical Theranostics Market Size Expected to Be by 2034?
The size of the radiopharmaceutical theranostics market has seen rapid expansion in the recent past. The market is expected to increase from…
The Surge In Cancer Incidence Boosts Radiopharmaceutical Theranostics Market Gro …
How Are the key drivers contributing to the expansion of the radiopharmaceutical theranostics market?
The growth of the radiopharmaceutical theranostics market is projected to be driven by the increasing occurrence of cancer. Cancer is a complicated disease characterized by the abnormal and excessive growth of cells, which can ultimately spread to other regions of the body. Radiopharmaceutical theranostics aids in fighting cancer through personalized and targeted methodologies. For example, as per…
Comprehensive Market Analysis on Theranostics Market projected to reach USD 5.4 …
Theranostics Market Scope:
Market size value in 2023 - USD 1.9 Billion
Market size value in 2030 - USD 5.4 Billion
CAGR (2023-2030) - 16.2%
Forecast Period - 2023-2030
Segments Covered - Product Type, Application, End Users and Region
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Abbott Laboratories, Advanced Accelerator Applications, AmeriPath, Bayer AG, Cardinal Health, Curium, GE HealthCare Technologies, Lantheus Medical Imaging, NuView Life…
Theranostics Market Report 2024: Strategies And Recent Developments | Abbott Lab …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2736
The Business Research Company offers in-depth market insights through Theranostics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The theranostics market size has grown rapidly in recent years. It will grow…
Sarcoma Drugs Market is Gaining Huge Growth in Upcoming Years
A new business intelligence report released by USD Analytics with the title ""Global Sarcoma Drugs Market Report 2030 "" identifies strong growth prospects across markets worldwide as companies continue to invest aggressively in new product launches and exploring niche market opportunities. The Global Sarcoma Drugs Market Report offers energetic visions to conclude and study the market size, market share analysis, and competitive landscape. The research is derived through primary and…
